Coronary revascularization in women

Clinical Cardiology

Volumn 35, Issue 3, 2012, Pages 156-159

  Lundberg, Gina ^a   King, Spencer ^a  

^a Saint Joseph's Heart and Vascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; SURGICAL MORTALITY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; WOMEN'S HEALTH;

ANGINA PECTORIS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; REGISTRIES; SEX FACTORS; WOMEN'S HEALTH;

EID: 84858045006     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21976     Document Type: Review

References (14)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and stroke statistics 2011 update: a report from the AHA. Circulation. 2011; 123: e18-e209.
2. Kim C, Redberg RF, Pavlic T, et al. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiology. 2007; 30: 491-495. (Pubitemid 47587501)
3. Boden WE, O'Rourke RA, Teo KK, et al. The COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516. (Pubitemid 46588415)
4. The BARI, 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360: 2503-2315.
5. Bairey Merz CN, Shaw LJ, Reis SE, et al. WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part II, gender differences in presentation, diagnosis, and outcomes with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006; 47 (3 suppl): S21-S29.
6. Duvernoy CS, Smith DE, Manohar P, et al. Gender difference in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Percutaneous Coronary Intervention Registry. Am Heart J. 2010; 159: 677-683.
7. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32: 2999-3054.
8. Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005; 111: 940-953. (Pubitemid 40282597)
9. Jackson EA, Moscucci M, Smith DE, et al. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J. 2011; 161: 106-112.e1
10. Humphries KH, Gao M, Pu A, et al. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol. 2007; 49: 1552-1558. (Pubitemid 46517951)
11. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011; 32: 2125-2134.
12. Mikhail GW, Gerber RT, Cox DA, et al. Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent. Results of the "TAXUS Woman" Analysis. JACC Cardiovasc Interv. 2010; 3: 1250-1259.
13. Serruys PW, Onuma Y, Garget S, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010; 55: 1093-1101.
14. Stefanini GG, Kalesan B, Pilgrim T, et al. Impact of gender on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv. In press, March 2012 Vol 5#3.